Transcript jw-platforms

Live Cell Imaging
Stem Cell Research
Jeanette Walker
24 June 2009
To help others…
Sponsors:
- find solutions to the challenges involved in
fundamental stem cell research as well as
the translation of stem cell research into
safe and affordable routine treatments for
patients
- accelerate the use of stem cells for nontherapeutic applications e.g. drug
discovery
EESCN’s Role
Academics
Businesses
Facilitate collaborations
• Regionally
EESCN
• Nationally
• Internationally
Free membership
Clinicians
Policy/Public
2004 - established
2007 - incorporated as
a limited company
(Not-for-profit)
EEDA funded
Self-financing
Board
• Dr Hermann Hauser
• Dr Cathy Prescott
• Dr Megan Davies
• Mr Julian Hitchcock
• Mr Richard Archer
Day to day management
• ERBI
• Jeanette Walker, Business Development
Director
Steering
Group
Dr Peter Hewkin, CEO, Cambridge Network
Dr Ron Zimmern, PHG Foundation
Professor Roger Pedersen, Cambridge University
Dr Andrea Kells, Cambridge University
Dr Dominic Clark , Sagentia
Dr Glyn Stacey , UK Stem Cell Bank
Dr Chris Bravery, ERA Consulting
Dr Suzanne Watts, NHSBT
Dr Finbarr Livesey, University of Cambridge
Professor Brian Salter, King’s College London
Mr Nigel Atkinson, Buddy for the MS Society
Dr Andy Richards
Dr Ruth McKernan, Pfizer Regenerative Medicine
Capabilities
• Fundamental Research
Bench
• Translational Research
Cambridge is building
the expertise & facilities
to translate science into
clinical practice
• Clinical Research
Bedside
Basic &
applied
Research
Cambridge...
Patient
groups
Production
facilities
Clinical
expertise
Clinical
research
Technical
services
Facilities
Finance
Professional
advisers
Website Registration
- News, jobs and events
- www.eescn.org.uk
Conclusion
“If DNA is the software of genetics, then
stem cells are its hardware. What
better place to study them than
Cambridge, where DNA was
discovered?”
Professor Stephen Hawking,
Lucasian Professor,
Cambridge University
Live cell imaging